Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan(®) Databases

INTRODUCTION: Limited real-world data are available comparing multiple biologics on their adherence, persistence, and the use of concomitant biologics in the treatment of moderate-to-severe psoriasis in clinical practice. The objective was to compare persistence of and adherence to ixekizumab (IXE)...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonardi, Craig, Zhu, Baojin, Malatestinic, William N., Eastman, William J., Guo, Jiaying, Murage, Mwangi J., Choong, Casey Kar-Chan, Burge, Russel, Blauvelt, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239953/
https://www.ncbi.nlm.nih.gov/pubmed/35570242
http://dx.doi.org/10.1007/s12325-022-02155-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239953/
https://www.ncbi.nlm.nih.gov/pubmed/35570242
http://dx.doi.org/10.1007/s12325-022-02155-9

Ejemplares similares